{"entity":{"type":"insider","cik":"0001966926","url":"/insider/0001966926","json_url":"/insider/0001966926.json","name":"Hyllengren Eric J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2023-05-18","last":"2025-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Hyllengren Eric J","source":"filing","n_filings":8,"first_seen":"2023-05-18","last_seen":"2025-03-05"}],"transactions":[{"id":4043047,"accession":"0000905148-25-000864","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-25-000864","line_url":"/filing/0000905148-25-000864#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001966926","owner_name":"Hyllengren Eric J","owner_display_name":"Hyllengren Eric J","owner_url":"/insider/0001966926","role":"Officer (EVP, CFO and COO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1211.0,"shares_display":"1,211","price_per_share":6.997,"price_display":"7.00","price_state":"stated","total_value":8473.367,"total_display":"8,473.37","total_whole":"8,473","shares_owned_after":56231.0,"shares_owned_after_display":"56,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":3150043,"accession":"0000905148-24-003242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-003242","line_url":"/filing/0000905148-24-003242#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001966926","owner_name":"Hyllengren Eric J","owner_display_name":"Hyllengren Eric J","owner_url":"/insider/0001966926","role":"Officer (EVP, CFO and COO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1364.0,"shares_display":"1,364","price_per_share":11.198,"price_display":"11.20","price_state":"stated","total_value":15274.072,"total_display":"15,274.07","total_whole":"15,274","shares_owned_after":23392.0,"shares_owned_after_display":"23,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-20","scope":"insider"},{"id":2764790,"accession":"0000905148-24-002303","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-24-002303","line_url":"/filing/0000905148-24-002303","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001966926","owner_name":"Hyllengren Eric J","owner_display_name":"Hyllengren Eric J","owner_url":"/insider/0001966926","role":"Officer (EVP, CFO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1070.0,"shares_display":"1,070","price_per_share":6.629054205607477,"price_display":"6.63","price_state":"stated","total_value":7093.088,"total_display":"7,093.09","total_whole":"7,093","shares_owned_after":24785.0,"shares_owned_after_display":"24,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-20","scope":"insider","n_lines":2},{"id":2233295,"accession":"0000905148-24-001558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-001558","line_url":"/filing/0000905148-24-001558#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001966926","owner_name":"Hyllengren Eric J","owner_display_name":"Hyllengren Eric J","owner_url":"/insider/0001966926","role":"Officer (EVP, CFO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28648.0,"shares_display":"28,648","price_per_share":0.617,"price_display":"0.62","price_state":"stated","total_value":17675.816,"total_display":"17,675.82","total_whole":"17,676","shares_owned_after":645671.0,"shares_owned_after_display":"645,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":2846749,"accession":"0000905148-24-000908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-24-000908","line_url":"/filing/0000905148-24-000908","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001966926","owner_name":"Hyllengren Eric J","owner_display_name":"Hyllengren Eric J","owner_url":"/insider/0001966926","role":"Officer (EVP, CFO)","role_mark":"O","role_mark_label":"Officer (EVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6679.0,"shares_display":"6,679","price_per_share":0.7202188950441683,"price_display":"0.72","price_state":"stated","total_value":4810.342,"total_display":"4,810.34","total_whole":"4,810","shares_owned_after":674319.0,"shares_owned_after_display":"674,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider","n_lines":2},{"id":8389098,"accession":"0000905148-23-001509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-23-001509","line_url":"/filing/0000905148-23-001509#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001966926","owner_name":"Hyllengren Eric J","owner_display_name":"Hyllengren Eric J","owner_url":"/insider/0001966926","role":"Officer (SVP, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11958.0,"shares_display":"11,958","price_per_share":0.389,"price_display":"0.39","price_state":"stated","total_value":4651.662,"total_display":"4,651.66","total_whole":"4,652","shares_owned_after":205998.0,"shares_owned_after_display":"205,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"},{"id":8676346,"accession":"0001140361-23-040564","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-040564","line_url":"/filing/0001140361-23-040564","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001966926","owner_name":"Hyllengren Eric J","owner_display_name":"Hyllengren Eric J","owner_url":"/insider/0001966926","role":"Officer (SVP, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8186.0,"shares_display":"8,186","price_per_share":1.6524344001954556,"price_display":"1.65","price_state":"stated","total_value":13526.828,"total_display":"13,526.83","total_whole":"13,527","shares_owned_after":219734.0,"shares_owned_after_display":"219,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-18","scope":"insider","n_lines":2},{"id":8604510,"accession":"0001140361-23-025558","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-025558","line_url":"/filing/0001140361-23-025558","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001966926","owner_name":"Hyllengren Eric J","owner_display_name":"Hyllengren Eric J","owner_url":"/insider/0001966926","role":"Officer (SVP, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7918.0,"shares_display":"7,918","price_per_share":2.037217100277848,"price_display":"2.04","price_state":"stated","total_value":16130.685,"total_display":"16,130.68","total_whole":"16,131","shares_owned_after":227861.0,"shares_owned_after_display":"227,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (EVP, CFO and COO)","n_filings":8,"first_seen":"2023-05-18","last_seen":"2025-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001966926","retrieved_at":"2026-08-26T21:41:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}